Study whether metabolic interventions can recruit oligodendrocyte-lineage cells for repair in progressive multiple sclerosis. The Blouet and Káradóttir laboratories combine demyelination models, pharmacological interventions, neuronal recordings, imaging and single-nucleus transcriptomics in a two-year translational research project.
In Biology and Cell Biology